https://www.selleckchem.com/pr....oducts/chroman-1.htm
The aim of this study is the predictive validation of red cell distribution width (RDW) in COVID-19 patients. In total, 331 COVID-19 patients were classified as 'severe' and 'nonsevere' groups based on the WHO standard criteria. The levels of RDW standard deviation (SD) were evaluated as both continuous and categorical variables. Multivariate statistical analyses were used. RDW-SD ≤43 and ≤47 flthresholds showed high specificity (90.1-91.4%) for diagnosing nonsevere illness and no risk of death. RDW-SD 47 indicated severe illness
Me gusta
Comentario
Compartir
